Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Among patients with previously treated advanced clear cell renal cell carcinoma (RCC) Welireg continued to show some benefits, though not to overall survival.
Alexandra Drakaki, MD, expands on the need to improve specific classifications in non–clear cell renal cell carcinoma.
Adam E. Singer, MD, PhD, details how he selects between the available TKI/IO combinations and the only dual immunotherapy regimen for patients with RCC.
Researchers in California have conducted research into tap water. Their findings raise concerns over tap water, but say bottled water is no safer
A PET radiotracer that detects clear-cell renal cell carcinoma proved safe and highly effective in a clinical trial conducted at 36 research hospitals across nine countries.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
David A. Braun, MD, PhD, discusses the role of biomarkers in guiding adjuvant treatment strategies for renal cell carcinoma.
... ccRCC and UC. The analysis included patients with stage IV ccRCC (15,926 individuals) or UC (10,380 individuals) identified from the National ...
Alexandra Drakaki, MD, PhD, discusses the potential role of zanzalintinib in advanced non–clear cell renal cell carcinoma.
Alectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Renal Cell Carcinoma.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.